A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice

Diabetologia
Alix BesançonSylvaine You

Abstract

The CD28/B7 interaction is critical for both effector T cell activation and forkhead box P3 (FOXP3)+ regulatory T cell (Treg) generation and homeostasis, which complicates the therapeutic use of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)-immunoglobulin fusion protein (CTLA-4Ig) in autoimmunity. Here, we evaluated the impact of a simultaneous and selective blockade of the CD28 and mammalian target of rapamycin (mTOR) pathways in the NOD mouse model of type 1 diabetes. NOD mice were treated with PEGylated anti-CD28 Fab' antibody fragments (PV1-polyethylene glycol [PEG], 10 mg/kg i.p., twice weekly), rapamycin (1 mg/kg i.p., twice weekly) or a combination of both drugs. Diabetes incidence, pancreatic islet infiltration and autoreactive T cell responses were analysed. We report that 4 week administration of PV1-PEG combined with rapamycin effectively controlled the progression of autoimmune diabetes in NOD mice at 10 weeks of age by reducing T cell activation and migration into the pancreas. Treatment with rapamycin alone was without effect, as was PV1-PEG monotherapy initiated at 4, 6 or 10 weeks of age. Prolonged PV1-PEG administration (for 10 weeks) accelerated diabetes development associated with impaired peripheral T...Continue Reading

References

Sep 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Qizhi TangJeffrey A Bluestone
Nov 28, 2012·The Journal of Experimental Medicine·David K FinlayDoreen A Cantrell
Jan 30, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·H XuA D Kirk
Dec 10, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·N PoirierG Blancho
Jan 16, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Krista G HaanstraBernard Vanhove
May 19, 2016·Immunity·Jonathan H EsenstenJeffrey A Bluestone
Nov 17, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nicolas PoirierBernard Vanhove
Jun 21, 2017·European Journal of Immunology·Laetitia LaurentFadi Fakhouri

❮ Previous
Next ❯

Citations

Sep 18, 2020·Nature Reviews. Drug Discovery·Natalie M EdnerLucy S K Walker
Jan 5, 2019·Biochemistry·Daniel F SheehyArturo J Vegas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.